Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 02, 2020

SELL
$1.15 - $2.1 $5,824 - $10,636
-5,065 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$0.48 - $1.67 $2,431 - $8,458
5,065 New
5,065 $6,000
Q4 2019

Feb 10, 2020

SELL
$0.96 - $2.94 $24,830 - $76,043
-25,865 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$0.58 - $3.01 $5,800 - $30,099
10,000 Added 63.03%
25,865 $67,000
Q2 2019

Aug 14, 2019

BUY
$1.47 - $3.16 $23,321 - $50,133
15,865 New
15,865 $27,000
Q1 2019

May 13, 2019

SELL
$2.56 - $4.48 $38,566 - $67,491
-15,065 Closed
0 $0
Q4 2018

Feb 11, 2019

BUY
$2.98 - $6.86 $44,893 - $103,345
15,065 New
15,065 $45,000

About T2 Biosystems, Inc.


  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $3.38M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.